Indigenous mRNA vaccine candidate supported by DBT gets Drug Controller nod to initiate Human clinical trials

DELHI, DECEMBER 11: India’s first indigenous mRNA vaccine candidate has received approval from Indian Drug regulators to initiate Phase I/II human clinical trial. The novel mRNA vaccine candidate, HGCO19 has been developed by Gennova, Pune and supported with seed grant under the Ind-CEPI mission of Department of Biotechnology […]